Influenza Diagnostics Market (Type: Type A, Type B, and Others; and Test Type: Molecular Assays and Antigen Detection Assays) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Publish Date: Feb 2023

Report Code: TMR3677A

Publisher: Transparency

Single User License: $5795

Explore Our Services

Already a member? Login here.

Report Highlights

Influenza Diagnostics Market – Scope of Report

TMR’s report on the global influenza diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global influenza diagnostics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global influenza diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the influenza diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global influenza diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global influenza diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global influenza diagnostics market.

The report delves into the competitive landscape of the global influenza diagnostics market. Key players operating in the global influenza diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global influenza diagnostics market profiled in this report.

Key Questions Answered in Global Influenza Diagnostics Market Report

  • What is the sales/revenue generated by influenza diagnostics across all regions during the forecast period?
  • What are the opportunities in the global influenza diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2023-2031
Units considered $ Million
Segments covered By Type, By Test Type, By Product Type, By End User, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Companies studied
  • 3M
  • Becton, Dickinson and Company
  • Abbott
  • Agilent Technologies, Inc
  • Luminex Corporation
  • BIOMERIEUX
  • Bio-Rad
  • GenMark Diagnostics, Inc
  • Hologic, Inc.
  • Meridian Bioscience, Inc. and Others.

Influenza Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global influenza diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global influenza diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global influenza diagnostics market.

  • Table 1 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 2 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by 2017‒2031, by Test Type
  • Table 3 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by 2017‒2031, by Product Type
  • Table 4 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 5 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 6 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 7 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 8 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 9 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
  • Table 10 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 11 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
  • Table 12 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 13 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 14 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
  • Table 15 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 16 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 17 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 18 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 19 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
  • Table 20 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 21 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 23 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 24 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
  • Table 25 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 26 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Type, 2017‒2031
  • Table 28 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017‒2031
  • Table 29 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2017‒2031
  • Table 30 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Figure 1 : Global Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Influenza Diagnostics Market Value Share, by Type, 2022
  • Figure 3 : Global Influenza Diagnostics Market Value Share, by Test Type, 2022
  • Figure 4 : Global Influenza Diagnostics Market Value Share, by Product Type, 2022
  • Figure 5 : Global Influenza Diagnostics Market Value Share, by End-user, 2022
  • Figure 6 : Global Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 7 : Global Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 8 : Global Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 9 : Global Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 10 : Global Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 11 : Global Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 12 : Global Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 13 : Global Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 14 : Global Influenza Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 15 : Global Influenza Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16 : North America Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 17 : North America Influenza Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18 : North America Influenza Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19 : North America Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 20 : North America Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 21 : North America Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 22 : North America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 23 : North America Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 24 : North America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 25 : North America Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26 : North America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27 : Europe Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 28 : Europe Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 29 : Europe Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30 : Europe Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 31 : Europe Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 32 : Europe Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 33 : Europe Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 34 : Europe Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 35 : Europe Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 36 : Europe Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 37 : Europe Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 38 : Asia Pacific Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 39 : Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 40 : Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41 : Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 42 : Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 43 : Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 44 : Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 45 : Asia Pacific Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 46 : Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 47 : Asia Pacific Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 48 : Asia Pacific Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49 : Latin America Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 50 : Latin America Influenza Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
  • Figure 51 : Latin America Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2022-2031
  • Figure 52 : Latin America Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 53 : Latin America Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 54 : Latin America Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 55 : Latin America Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 56 : Latin America Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 57 : Latin America Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 58 : Latin America Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 59 : Latin America Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 60 : Middle East & Africa Influenza Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 61 : Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
  • Figure 62 : Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Country/Sub-Region, 2022-2031
  • Figure 63 : Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 64 : Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 65 : Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 66 : Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 67 : Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 68 : Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 69 : Middle East & Africa Influenza Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 70 : Middle East & Africa Influenza Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 71 : Company Share Analysis, 2022

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Influenza Diagnostics Market (Type: Type A, Type B, and Others; and Test Type: Molecular Assays and Antigen Detection...